XML 43 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Summary of Significant Accounting Policies          
Number of operating segments | segment     1    
In-process R&D, carrying value $ 19,614,000   $ 19,614,000   $ 17,358,000
In-process R&D, impairment charges 0 $ 1,325,000   $ 1,325,000  
Impairment charge 0 0 $ 0 0  
Research and Development Program          
Summary of Significant Accounting Policies          
Research and development expenditure period (in months)     24 months    
In-process R&D          
Summary of Significant Accounting Policies          
Impairments $ 0   $ 0    
In-process R&D, carrying value   19,800,000   19,800,000  
In-process R&D, written down and fair value   18,600,000   18,600,000  
In-process R&D, impairment charges   $ 1,300,000 $ 0 $ 1,300,000